Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Javier Martinez-Poles"'
Autor:
Javier Martinez‐Poles, Ana Isabel Saldaña‐Díaz, Jaime Esteban, Mónica Lara‐Almunia, Anthony Tito Vizarreta Figueroa, Leticia Martín‐Gil, José Cebrián‐Escudero, José Fernández‐Ferro
Publikováno v:
European Journal of Neurology. 30:1152-1154
Autor:
Nuria López Ariztegui, Marina Mata Alvarez-Santullano, Iciar Tegel, Francisca Almeida, Pilar Sarasa, Rosa Rojo, Fernando Rico-Villademoros, Javier Abril Jaramillo, Pedro Bermejo, Carmen Borrue, Nuria Caballol, Marina Campins Romeu, Pedro Clavero, Juan García Caldentey, Victor Gómez Mayordomo, Carmen Labandeira, Glòria Martí Andrés, Juan Carlos Martínez Castrillo, Javier Martinez Poles, Teresa Muñoz, José María Salom, Carmen Valderrama Martín, Ana Vinagre Aragón
Publikováno v:
REVISTA DE NEUROLOGIA
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Opicapone is a catechol-O-methyl-transferase (iCOMT) inhibitor authorized in Europe in 2016 and indicated as adjunctive therapy to preparations of levodopa/ DOPA decarboxylase inhibitors in adult patients with Parkinson's disease and end-of-dose moto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbb1f6170d3cedd5909a718655cf1224
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15285
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15285
Autor:
Velina Nedkova-Hristova, José Bernardo Escribano-Paredes, Sebastián García-Madrona, Adriano Jimenez-Escrig, Javier Martinez-Poles
Publikováno v:
Neurology. 94(2)
A 22-year-old man with Alexander disease type II diagnosed by a compatible MRI with bilateral white matter hyperintensities and brainstem atrophy (figure) and mutation c.236G>A (p.Arg79His) in the GFAP gene presented with recent onset continuous pala
Autor:
Elena Natera-Villalba, Araceli Alonso-Canovas, José Luis López-Sendón Moreno, Velina Nedkova-Hristova, Carlos Estevez-Fraga, Icíar Avilés-Olmos, José Bernardo Escribano-Paredes, Gema Sánchez Díaz, Javier Martinez-Poles, Sebastián García-Madrona, Juan Carlos Martínez Castrillo
Publikováno v:
Toxins, Vol 10, Iss 6, p 217 (2018)
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Toxins; Volume 10; Issue 6; Pages: 217
Toxins
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Toxins; Volume 10; Issue 6; Pages: 217
Toxins
Botulinum toxin type A is one of the most useful treatments of sialorrhea in neurological disorders. Evidence for the use of incobotulinumtoxin A (inco-A) in the treatment of sialorrhea is limited. Thirty-six patients with sialorrhea were treated wit
Autor:
Bhagteshwar Singh, Suzannah Lant, Sofia Cividini, Jonathan W. S. Cattrall, Lynsey C. Goodwin, Laura Benjamin, Benedict D. Michael, Ayaz Khawaja, Aline de Moura Brasil Matos, Walid Alkeridy, Andrea Pilotto, Durjoy Lahiri, Rebecca Rawlinson, Sithembinkosi Mhlanga, Evelyn C. Lopez, Brendan F. Sargent, Anushri Somasundaran, Arina Tamborska, Glynn Webb, Komal Younas, Yaqub Al Sami, Heavenna Babu, Tristan Banks, Francesco Cavallieri, Matthew Cohen, Emma Davies, Shalley Dhar, Anna Fajardo Modol, Hamzah Farooq, Jeffrey Harte, Samuel Hey, Albert Joseph, Dileep Karthikappallil, Daniel Kassahun, Gareth Lipunga, Rachel Mason, Thomas Minton, Gabrielle Mond, Joseph Poxon, Sophie Rabas, Germander Soothill, Marialuisa Zedde, Konstantin Yenkoyan, Bruce Brew, Erika Contini, Lucette Cysique, Xin Zhang, Pietro Maggi, Vincent van Pesch, Jérome Lechien, Sven Saussez, Alex Heyse, Maria Lúcia Brito Ferreira, Cristiane N. Soares, Isabel Elicer, Laura Eugenín-von Bernhardi, Waleng Ñancupil Reyes, Rong Yin, Mohammed A. Azab, Foad Abd-Allah, Ahmed Elkady, Simon Escalard, Jean-Christophe Corvol, Cécile Delorme, Pierre Tattevin, Kévin Bigaut, Norbert Lorenz, Daniel Hornuss, Jonas Hosp, Siegbert Rieg, Dirk Wagner, Benjamin Knier, Paul Lingor, Andrea Sylvia Winkler, Athena Sharifi-Razavi, Shima T. Moein, SeyedAhmad SeyedAlinaghi, Saeidreza JamaliMoghadamSiahkali, Mauro Morassi, Alessandro Padovani, Marcello Giunta, Ilenia Libri, Simone Beretta, Sabrina Ravaglia, Matteo Foschi, Paolo Calabresi, Guido Primiano, Serenella Servidei, Nicola Biagio Mercuri, Claudio Liguori, Mariangela Pierantozzi, Loredana Sarmati, Federica Boso, Silvia Garazzino, Sara Mariotto, Kimani N. Patrick, Oana Costache, Alexander Pincherle, Frederikus A. Klok, Roger Meza, Verónica Cabreira, Sofia R. Valdoleiros, Vanessa Oliveira, Igor Kaimovsky, Alla Guekht, Jasmine Koh, Eva Fernández Díaz, José María Barrios-López, Cristina Guijarro-Castro, Álvaro Beltrán-Corbellini, Javier Martínez-Poles, Alba María Diezma-Martín, Maria Isabel Morales-Casado, Sergio García García, Gautier Breville, Matteo Coen, Marjolaine Uginet, Raphaël Bernard-Valnet, Renaud Du Pasquier, Yildiz Kaya, Loay H. Abdelnour, Claire Rice, Hamish Morrison, Sylviane Defres, Saif Huda, Noelle Enright, Jane Hassell, Lucio D’Anna, Matthew Benger, Laszlo Sztriha, Eamon Raith, Krishna Chinthapalli, Ross Nortley, Ross Paterson, Arvind Chandratheva, David J. Werring, Samir Dervisevic, Kirsty Harkness, Ashwin Pinto, Dinesh Jillella, Scott Beach, Kulothungan Gunasekaran, Ivan Rocha Ferreira Da Silva, Krishna Nalleballe, Jonathan Santoro, Tyler Scullen, Lora Kahn, Carla Y. Kim, Kiran T. Thakur, Rajan Jain, Thirugnanam Umapathi, Timothy R. Nicholson, James J. Sejvar, Eva Maria Hodel, The Brain Infections Global COVID-Neuro Network Study Group, Catrin Tudur Smith, Tom Solomon
Publikováno v:
PLoS ONE, Vol 17, Iss 6 (2022)
Background Neurological COVID-19 disease has been reported widely, but published studies often lack information on neurological outcomes and prognostic risk factors. We aimed to describe the spectrum of neurological disease in hospitalised COVID-19 p
Externí odkaz:
https://doaj.org/article/095733b27c4d4df5a2a5be6cdb896396
Autor:
Javier Martínez-Poles, Velina Nedkova-Hristova, José Bernardo Escribano-Paredes, Sebastián García-Madrona, Elena Natera-Villalba, Carlos Estévez-Fraga, José Luis López-Sendón Moreno, Icíar Avilés-Olmos, Gema Sánchez Díaz, Juan Carlos Martínez Castrillo, Araceli Alonso-Canovas
Publikováno v:
Toxins, Vol 10, Iss 6, p 217 (2018)
Botulinum toxin type A is one of the most useful treatments of sialorrhea in neurological disorders. Evidence for the use of incobotulinumtoxin A (inco-A) in the treatment of sialorrhea is limited. Thirty-six patients with sialorrhea were treated wit
Externí odkaz:
https://doaj.org/article/24a1a7a5aa21429584b6adc83391c5b4